FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309207003> ?p ?o ?g. }

• W4309207003 abstract "Background In Saudi Arabia, sickle cell disease (SCD) is a major public health issue, especially in the eastern region. Sickle cell patients have major health-related issues, resulting in a poor quality of life and increased morbidity. Abnormal hemoglobin production in SCD causes various complications, such as vaso-occlusive crises, hemolytic episodes, and acute chest syndrome. These disease manifestations increase the need for hospital admission and long-term care. Most therapies for SCD are supportive and include episodic red blood cell transfusions, narcotics, antibiotics, and intravenous fluids. Hydroxyurea is a disease-modifying therapy. This study aimed to assess the effectiveness of hydroxyurea therapy on reducing pain crises, hospital admissions, and length of stay for SCD patients and discern reasons that would prevent SCD patients from using hydroxyurea as a treatment option. Methodology We conducted a descriptive cross-sectional study on SCD patients from the eastern Saudi Arabian province. The study included 202 SCD patients from hematology clinics and medical wards. We used a validated questionnaire tested for reliability after a pilot study of 15 randomly selected patients. We surveyed participants on demographic data, use of hydroxyurea, compliance with the regimen, hospitalization rates, durations, and complications. The study used IBM SPSS Statistics for Windows, Version 22.0. (IBM Corp., Armonk, NY) to analyze the data. All statistical analysis was done using two-tailed tests. P-values < 0.05 were considered statistically significant. Results The study included 202 participants who agreed to participate and completed the study questionnaire. The respondents comprised 150 SCD patients (74.3%) and 52 caregivers of SCD patients (25.7%). Patient ages ranged from one year to older than 36 years (mean age: 26.8 ± 12.3 years). The most common reason for not using hydroxyurea was that it was never offered to patients as a treatment option (40.9% of respondents), followed by respondents who had never heard of it (34.4%), think that they do not need it (24.7%), and fears of long-term consequences (23.7%). More hydroxyurea users (35.1%) suffered no acute painful crises during the last year than nonusers (32%), and more nonusers suffered more than four crises (20%) than hydroxyurea users (9.1%; p=.046). As for hospitalization due to SCD-related complications, 66.2% of hydroxyurea users were never hospitalized, while 51.2% of nonusers were never hospitalized. While 19.5% of hydroxyurea users were hospitalized one to two times, 28.8% of nonusers were hospitalized one to two times (p=.049). Conclusions The study revealed that hydroxyurea is effective in reducing painful vaso-occlusive crises and the number of hospital admissions. The prevalence of hydroxyurea use among SCD patients in the eastern province of Saudi Arabia remains low. Therefore, education campaigns and programs to increase awareness among health care providers regarding the benefits of hydroxyurea use are warranted in our region to help improve patient outcomes." @default.
• W4309207003 created "2022-11-24" @default.
• W4309207003 creator A5024737521 @default.
• W4309207003 creator A5050132408 @default.
• W4309207003 creator A5067480178 @default.
• W4309207003 creator A5078860562 @default.
• W4309207003 creator A5078924683 @default.
• W4309207003 creator A5087620973 @default.
• W4309207003 date "2022-11-15" @default.
• W4309207003 modified "2023-09-26" @default.
• W4309207003 title "Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia" @default.
• W4309207003 cites W1933659309 @default.
• W4309207003 cites W1963574634 @default.
• W4309207003 cites W1967354181 @default.
• W4309207003 cites W1976961587 @default.
• W4309207003 cites W2008021317 @default.
• W4309207003 cites W2010245909 @default.
• W4309207003 cites W2013495035 @default.
• W4309207003 cites W2023039510 @default.
• W4309207003 cites W2025536685 @default.
• W4309207003 cites W2039423483 @default.
• W4309207003 cites W2043184343 @default.
• W4309207003 cites W2056639134 @default.
• W4309207003 cites W2058679996 @default.
• W4309207003 cites W2061599979 @default.
• W4309207003 cites W2065773232 @default.
• W4309207003 cites W2078370121 @default.
• W4309207003 cites W2084545751 @default.
• W4309207003 cites W2109004143 @default.
• W4309207003 cites W2124240321 @default.
• W4309207003 cites W2150520883 @default.
• W4309207003 cites W2257876134 @default.
• W4309207003 cites W2313541759 @default.
• W4309207003 cites W2394616978 @default.
• W4309207003 cites W2478132734 @default.
• W4309207003 cites W2555542859 @default.
• W4309207003 cites W2769222556 @default.
• W4309207003 cites W2962733167 @default.
• W4309207003 cites W2980799643 @default.
• W4309207003 cites W3102864301 @default.
• W4309207003 cites W84713389 @default.
• W4309207003 doi "https://doi.org/10.7759/cureus.31527" @default.
• W4309207003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36540486" @default.
• W4309207003 hasPublicationYear "2022" @default.
• W4309207003 type Work @default.
• W4309207003 citedByCount "0" @default.
• W4309207003 crossrefType "journal-article" @default.
• W4309207003 hasAuthorship W4309207003A5024737521 @default.
• W4309207003 hasAuthorship W4309207003A5050132408 @default.
• W4309207003 hasAuthorship W4309207003A5067480178 @default.
• W4309207003 hasAuthorship W4309207003A5078860562 @default.
• W4309207003 hasAuthorship W4309207003A5078924683 @default.
• W4309207003 hasAuthorship W4309207003A5087620973 @default.
• W4309207003 hasBestOaLocation W43092070031 @default.
• W4309207003 hasConcept C126322002 @default.
• W4309207003 hasConcept C159110408 @default.
• W4309207003 hasConcept C187212893 @default.
• W4309207003 hasConcept C194828623 @default.
• W4309207003 hasConcept C2778620579 @default.
• W4309207003 hasConcept C2779134260 @default.
• W4309207003 hasConcept C2779951463 @default.
• W4309207003 hasConcept C2780976302 @default.
• W4309207003 hasConcept C71924100 @default.
• W4309207003 hasConceptScore W4309207003C126322002 @default.
• W4309207003 hasConceptScore W4309207003C159110408 @default.
• W4309207003 hasConceptScore W4309207003C187212893 @default.
• W4309207003 hasConceptScore W4309207003C194828623 @default.
• W4309207003 hasConceptScore W4309207003C2778620579 @default.
• W4309207003 hasConceptScore W4309207003C2779134260 @default.
• W4309207003 hasConceptScore W4309207003C2779951463 @default.
• W4309207003 hasConceptScore W4309207003C2780976302 @default.
• W4309207003 hasConceptScore W4309207003C71924100 @default.
• W4309207003 hasLocation W43092070031 @default.
• W4309207003 hasLocation W43092070032 @default.
• W4309207003 hasLocation W43092070033 @default.
• W4309207003 hasOpenAccess W4309207003 @default.
• W4309207003 hasPrimaryLocation W43092070031 @default.
• W4309207003 hasRelatedWork W152630169 @default.
• W4309207003 hasRelatedWork W2012774751 @default.
• W4309207003 hasRelatedWork W2051711579 @default.
• W4309207003 hasRelatedWork W242090125 @default.
• W4309207003 hasRelatedWork W2539600999 @default.
• W4309207003 hasRelatedWork W2588514944 @default.
• W4309207003 hasRelatedWork W2754302395 @default.
• W4309207003 hasRelatedWork W2901334784 @default.
• W4309207003 hasRelatedWork W3214088720 @default.
• W4309207003 hasRelatedWork W4252966358 @default.
• W4309207003 isParatext "false" @default.
• W4309207003 isRetracted "false" @default.
• W4309207003 workType "article" @default.